On June 3, Infleqtion declined 8.66% in regular trading, trading at $18.06/share, with trading volume of $123 million.

On the news front, Director David B. Singer, through MAVERICK CAPITAL LTD and related funds, cumulatively sold over 11.3 million shares of common stock in late May at prices ranging from $14.69 to $17.04 per share. The large-scale concentrated reduction signals that a major financial investor is realizing gains at current valuation levels, extending selling pressure on the stock.

The company had previously rallied sharply on multiple catalysts, including a roughly $100 million preliminary terms agreement under the CHIPS Act with the U.S. Department of Commerce, the announcement of a new Quantum Innovation Centre in Oxford tripling UK R&D capacity, and CEO Matt Kinsella's appearance at the Evercore TMT conference on June 2. The stock experienced a similar approximately 8.5% pullback on May 29 driven by the same profit-taking and insider-reduction dynamics, suggesting the current decline follows a consistent pattern of post-rally consolidation.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)